<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen SL</submitter><funding>MOH | National Medical Research Council</funding><funding>Agency for Science, Technology and Research</funding><funding>Genome Institute of Singapore</funding><pagination>13245</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6744567</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(1)</volume><pubmed_abstract>The ST131 multilocus sequence type (MLST) of Escherichia coli is a globally successful pathogen whose dissemination is increasing rates of antibiotic resistance. Numerous global surveys have demonstrated the pervasiveness of this clone; in some regions ST131 accounts for up to 30% of all E. coli isolates. However, many regions are underrepresented in these published surveys, including Africa, South America, and Asia. We collected consecutive bloodstream E. coli isolates from three countries in Southeast Asia; ST131 was the most common MLST type. As in other studies, the C2/H30Rx clade accounted for the majority of ST131 strains. Clinical risk factors were similar to other reported studies. However, we found that nearly all of the C2 strains in this study were closely related, forming what </pubmed_abstract><journal>Scientific reports</journal><pubmed_title>The higher prevalence of extended spectrum beta-lactamases among Escherichia coli ST131 in Southeast Asia is driven by expansion of a single, locally prevalent subclone.</pubmed_title><pmcid>PMC6744567</pmcid><funding_grant_id>IAF311018</funding_grant_id><funding_grant_id>NMRC/OFIRG/0009/2016</funding_grant_id><funding_grant_id>NMRC/CIRG/1467/2017</funding_grant_id><funding_grant_id>NMRC/CIRG/1357/2013</funding_grant_id><pubmed_authors>Lye DC</pubmed_authors><pubmed_authors>Kalimuddin S</pubmed_authors><pubmed_authors>Wong JGX</pubmed_authors><pubmed_authors>Apisarnthanarak A</pubmed_authors><pubmed_authors>Atiya N</pubmed_authors><pubmed_authors>Velayuthan RD</pubmed_authors><pubmed_authors>Omar SFS</pubmed_authors><pubmed_authors>Chen SL</pubmed_authors><pubmed_authors>Ding Y</pubmed_authors><pubmed_authors>De PP</pubmed_authors><pubmed_authors>Chew KL</pubmed_authors><pubmed_authors>Koh TH</pubmed_authors><pubmed_authors>Archuleta S</pubmed_authors><pubmed_authors>Suwantarat N</pubmed_authors></additional><is_claimable>false</is_claimable><name>The higher prevalence of extended spectrum beta-lactamases among Escherichia coli ST131 in Southeast Asia is driven by expansion of a single, locally prevalent subclone.</name><description>The ST131 multilocus sequence type (MLST) of Escherichia coli is a globally successful pathogen whose dissemination is increasing rates of antibiotic resistance. Numerous global surveys have demonstrated the pervasiveness of this clone; in some regions ST131 accounts for up to 30% of all E. coli isolates. However, many regions are underrepresented in these published surveys, including Africa, South America, and Asia. We collected consecutive bloodstream E. coli isolates from three countries in Southeast Asia; ST131 was the most common MLST type. As in other studies, the C2/H30Rx clade accounted for the majority of ST131 strains. Clinical risk factors were similar to other reported studies. However, we found that nearly all of the C2 strains in this study were closely related, forming what </description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Sep</publication><modification>2026-05-04T18:08:05.164Z</modification><creation>2019-10-11T07:05:26Z</creation></dates><accession>S-EPMC6744567</accession><cross_references><pubmed>31519972</pubmed><doi>10.1038/s41598-019-49467-5</doi></cross_references></HashMap>